Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bladder instillation WITH triamcinolone acetonide[1] Triamcinolone (Synonym: Triamcinolone Acetonide)[1] D00385 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 226
2Bladder instillation WITHOUT triamcinolone acetonide[1] Triamcinolone (Synonym: Triamcinolone Acetonide)[1] D00385 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 226
3Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP[5] Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone (Synonym: Triamcinolone Acetonide)		[5] D00385 ,
D00472 ,
D00592 ,
D00752 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 162
4Triamcinolone Acetonide[1] Triamcinolone (Synonym: Triamcinolone Acetonide)[1] D00385 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 35, 46, 56
5Triamcinolone Acetonide and normal saline solution[1] Triamcinolone (Synonym: Triamcinolone Acetonide)[1] D00385 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 70